Oppenheimer & Co’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.83M | Sell |
20,261
-102
| -0.5% | -$9.36K | 0.02% | 621 |
|
|
2025
Q4 | $1.83M | Buy |
20,363
+152
| +0.8% | +$14.4K | 0.03% | 572 |
|
|
2025
Q3 | $1.99M | Sell |
20,211
-1,866
| -8% | -$185K | 0.02% | 611 |
|
|
2025
Q2 | $2.01M | Sell |
22,077
-1,615
| -7% | -$156K | 0.03% | 572 |
|
|
2025
Q1 | $2.68M | Buy |
23,692
+101
| +0.4% | +$10.8K | 0.04% | 469 |
|
|
2024
Q4 | $2.49M | Sell |
23,591
-1,404
| -6% | -$151K | 0.04% | 488 |
|
|
2024
Q3 | $2.7M | Buy |
24,995
+1,977
| +9% | +$216K | 0.04% | 452 |
|
|
2024
Q2 | $2.5M | Sell |
23,018
-41
| -0.2% | -$4.83K | 0.04% | 461 |
|
|
2024
Q1 | $3.04M | Buy |
23,059
+214
| +0.9% | +$26.7K | 0.05% | 398 |
|
|
2023
Q4 | $2.78M | Buy |
22,845
+2,495
| +12% | +$278K | 0.05% | 409 |
|
|
2023
Q3 | $2.28M | Sell |
20,350
-2,238
| -10% | -$284K | 0.05% | 423 |
|
|
2023
Q2 | $3.29M | Buy |
22,588
+2,567
| +13% | +$349K | 0.07% | 324 |
|
|
2023
Q1 | $2.59M | Buy |
20,021
+256
| +1% | +$32.1K | 0.05% | 385 |
|
|
2022
Q4 | $2.52M | Sell |
19,765
-278
| -1% | -$32.3K | 0.06% | 381 |
|
|
2022
Q3 | $2.1M | Sell |
20,043
-1,494
| -7% | -$164K | 0.05% | 415 |
|
|
2022
Q2 | $2.26M | Buy |
21,537
+155
| +0.7% | +$18.4K | 0.05% | 426 |
|
|
2022
Q1 | $2.73M | Sell |
21,382
-5,131
| -19% | -$618K | 0.05% | 422 |
|
|
2021
Q4 | $3.27M | Buy |
26,513
+8,400
| +46% | +$1.1M | 0.06% | 375 |
|
|
2021
Q3 | $2.57M | Buy |
18,113
+3,650
| +25% | +$537K | 0.05% | 430 |
|
|
2021
Q2 | $2.26M | Buy |
14,463
+4,471
| +45% | +$724K | 0.04% | 479 |
|
|
2021
Q1 | $1.55M | Sell |
9,992
-335
| -3% | -$51.9K | 0.03% | 545 |
|
|
2020
Q4 | $1.54M | Buy |
10,327
+95
| +0.9% | +$13.4K | 0.03% | 510 |
|
|
2020
Q3 | $1.35M | Sell |
10,232
-6,841
| -40% | -$894K | 0.03% | 481 |
|
|
2020
Q2 | $1.98M | Sell |
17,073
-2,014
| -11% | -$232K | 0.05% | 387 |
|
|
2020
Q1 | $1.87M | Buy |
19,087
+1,262
| +7% | +$165K | 0.06% | 351 |
|
|
2019
Q4 | $2.59M | Buy |
17,825
+1,364
| +8% | +$188K | 0.06% | 339 |
|
|
2019
Q3 | $2.19M | Sell |
16,461
-10,786
| -40% | -$1.39M | 0.06% | 377 |
|
|
2019
Q2 | $3.12M | Sell |
27,247
-2,339
| -8% | -$274K | 0.08% | 269 |
|
|
2019
Q1 | $3.67M | Buy |
29,586
+756
| +3% | +$85.9K | 0.1% | 237 |
|
|
2018
Q4 | $2.9M | Sell |
28,830
-366
| -1% | -$41.2K | 0.09% | 249 |
|
|
2018
Q3 | $3.73M | Sell |
29,196
-5,272
| -15% | -$627K | 0.09% | 242 |
|
|
2018
Q2 | $3.73M | Sell |
34,468
-330
| -0.9% | -$35.9K | 0.1% | 227 |
|
|
2018
Q1 | $3.68M | Sell |
34,798
-849
| -2% | -$98.6K | 0.09% | 239 |
|
|
2017
Q4 | $4.18M | Sell |
35,647
-1,474
| -4% | -$167K | 0.11% | 223 |
|
|
2017
Q3 | $4.22M | Buy |
37,121
+4,072
| +12% | +$470K | 0.11% | 217 |
|
|
2017
Q2 | $4.12M | Buy |
33,049
+8,907
| +37% | +$1.06M | 0.11% | 223 |
|
|
2017
Q1 | $2.86M | Buy |
24,142
+434
| +2% | +$49.2K | 0.08% | 294 |
|
|
2016
Q4 | $2.38M | Buy |
23,708
+17,937
| +311% | +$1.92M | 0.07% | 326 |
|
|
2016
Q3 | $728K | Sell |
5,771
-64
| -1% | -$7.91K | 0.02% | 670 |
|
|
2016
Q2 | $682K | Buy |
5,835
+545
| +10% | +$61.7K | 0.02% | 673 |
|
|
2016
Q1 | $548K | Buy |
5,290
+1,041
| +24% | +$101K | 0.02% | 720 |
|
|
2015
Q4 | $423K | Sell |
4,249
-1,372
| -24% | -$134K | 0.01% | 827 |
|
|
2015
Q3 | $512K | Sell |
5,621
-43
| -0.8% | -$4.31K | 0.02% | 795 |
|
|
2015
Q2 | $600K | Buy |
5,664
+391
| +7% | +$43.3K | 0.02% | 801 |
|
|
2015
Q1 | $602K | Buy |
5,273
+1,192
| +29% | +$136K | 0.02% | 796 |
|
|
2014
Q4 | $449K | Sell |
4,081
-478
| -10% | -$50.4K | 0.01% | 866 |
|
|
2014
Q3 | $444K | Buy |
4,559
+1,045
| +30% | +$103K | 0.01% | 897 |
|
|
2014
Q2 | $354K | Sell |
3,514
-747
| -18% | -$72.9K | 0.01% | 990 |
|
|
2014
Q1 | $392K | Sell |
4,261
-816
| -16% | -$75.2K | 0.01% | 925 |
|
|
2013
Q4 | $460K | Sell |
5,077
-533
| -10% | -$46.1K | 0.01% | 843 |
|
|
2013
Q3 | $448K | Sell |
5,610
-113
| -2% | -$8.89K | 0.02% | 790 |
|
|
2013
Q2 | $416K | Buy |
+5,723
| New | +$428K | 0.02% | 786 |
|
Other funds holding ZBH
VCM
VPM
Oppenheimer & Co's ZBH Position: Q1 2026 in Review
Oppenheimer & Co reduced its Zimmer Biomet (ZBH) stake by 0.5% in Q1 2026, selling an estimated $9.36K and leaving 20,261 shares worth $1.83M. The position accounts for 0.02% of the portfolio, ranked #621.
Oppenheimer & Co first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.22M in Q3 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Oppenheimer & Co held 20,261 shares of Zimmer Biomet worth $1.83M as of Q1 2026.
- Oppenheimer & Co sold 102 Zimmer Biomet shares in Q1 2026, an estimated $9.36K.
- Zimmer Biomet made up 0.02% of Oppenheimer & Co's portfolio in Q1 2026, its #621 holding.
- Oppenheimer & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- Oppenheimer & Co's Zimmer Biomet position peaked at $4.22M in Q3 2017.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.